Soichiro Yokota

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104

Minoru Takada, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 2002 · 704 citations

Medicine, Oncology, Radiation Oncology +14

Interstitial Lung Disease in Japanese Patients with Lung Cancer

Shoji Kudoh, Harubumi Kato, Yutaka Nishiwaki et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 488 citations

Medicine, Oncology, Pharmacology +15

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Nobuyuki Yamamoto, Kazuhiko Nakagawa, Yasumasa Nishimura et al. · Journal of Clinical Oncology · 2010 · 304 citations · Full text

Medicine, Oncology, Radiation Oncology +10

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy

Junichi Azuma, Masako Ohno, Ryuji Kubota et al. · European Journal of Clinical Pharmacology · 2012 · 273 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

Masako Ohno, Ichiro Yamaguchi, Itiro Yamamoto et al. · PubMed · 2000 · 255 citations

Veterinary Medicine, Genetics, Pharmacology +15